26 Novembre 2017

Olea Medical® signs a partnership agreement with the US company Qmetrics Technologies

Olea Medical® integrates the cartilage segmentation technology developed by Qmetrics Technologies into Olea Sphere®V3.0.

La Ciotat, France – Olea Medical® is pleased to announce that it has signed a partnership agreement with Qmetrics Technologies, a provider of segmentation and 3D modeling services. Olea Medical®, a Toshiba Medical Systems Corporation company, will now include the cartilage segmentation technology developed by the US company in its Olea Sphere® V3.0 software suite. “We are always looking to provide our customers with enhanced and expanded imaging capabilities and this is a significant add-on to our advanced MSK solutions offering”, said Fayçal Djeridane, Olea Medical®’s Chief Executive Officer. ”Radiologists specialized in MSK and sports medicine worldwide will have access to innovative advanced postprocessing technology allowing them to deliver better patient care in their daily practice.”

According to Bruno Triaire, Olea Medical®’s Chief Medical Officer, “This will allow us to expand our osteoarticular MRI services by adding automatic cartilage segmentation. Degenerative cartilage pathologies are becoming increasingly common and new treatments depend on this technology. This solution will help us consolidate our position as an MRI imaging expert in the sports medicine field.”
“Through this partnership, we can help Olea Medical® bring advanced cartilage segmentation capabilities to its customers, as an additional benefit for them,” commented Edward Schreyer, CEO, Qmetrics Technologies. “The agreement helps us to further our goal of bringing advanced imaging information to patients and care providers.”

Téléchargez la revue complète